*Please note that Small GTPases converted to a full Open Access journal from Volume 14 (2023). Previous volumes will continue to provide access through a Pay to Read model.
Small GTPases have emerged as key signal transducing proteins involved in every facet of cell and organismal biology. To reflect their prominence in health and disease, the journal Small GTPases aims to be a dedicated forum for the sharing of information at the forefront of the field, covering a broad range of research including cell and in vivo biology, structural studies, biochemistry, and drug discovery. In addition to the GTPase proteins themselves, Small GTPases features research focused on the structure, regulation, and function of their regulators and effectors. To reflect the advances in methodologies used for biological research, Small GTPases is particularly interested in manuscripts that make use of emerging approaches, including systems biology, biophysics, advanced imaging and, bioinformatics. These approaches complement classical experimental techniques to discover the underlying mechanisms that small GTPases employ to regulate fundamental biological processes.
Small GTPases publishes 6 issues per year and accepts:
Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.
Journal metrics
Usage
131K annual downloads/views
Citation metrics
6.1 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.532 (2023) SNIP
0.942 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editorial Board Pontus Aspenström - Karolinska Institutet, Stockholm, SE Dafna Bar-Sagi - New York University, New York, New York, US Vania M.M. Braga - Imperial College of London, London, England, UK Cord Brakebusch - University of Copenhagen, Copenhagen, DK Xosé R. Bustelo - University of Salamanca, Salamanca, ES Richard Cerione - Cornell University, Ithaca, NY Jacqueline Cherfils - LEBS,CNRS, Gif-sur-Yvette, FR Adrienne D. Cox - University of North Carolina, Chapel Hill, NC, US Crislyn D'Souza-Schorey - University of Notre Dame, Notre Dame, IN, US Anne Debant - Centre de Recherché de Biochimie Macromoléculaire; CNRS, Montpellier, FR Channing J. Der - University of North Carolina, Chapel Hill, NC, US Sandrine Etienne-Manneville - Institute Curie, CNRS, Paris, FR Stéphane Gasman - Cellular and Integrative Neuroscience Institute (INCI, CNRS) Université de Strasbourg, Strasbourg, France Andrew B. Goryachev - University of Edinburgh, Edinburgh, UK Bruno Goud - Institut Curie, CNRS, Paris, FR Bengt Hallberg - Umeå University, Umeå, SE Shehab Ismail - Cancer Research UK, Beatson Institute, Glasgow, UK Johanna Ivaska - University of Turku, Turku, FI Richard A. Kahn - Emory University School of Medicine, Atlanta, GA, US Erik A Lundquist - University of Kansas, Lawrence, KS, US Angeliki Malliri - The University of Manchester, Manchester, England, UK Harry Mellor - University of Bristol, Bristol, England, UK Darerca Owen - Cambridge University, Cambridge , UK Mark Philips - New York University, New York, New York, US Lawrence Quilliam - Indiana University, Bloomington, IN, US Michael Rogers - Garvin Institute, Sydney, AU Klemens Rottner - Helmholtz Centre for Infection Research, Braunschweig, DE Erik Sahai - The Francis Crick Institute, London, UK Victoria Sanz-Moreno - King's College London, London, UK Michael Way - Cancer Research UK; London Research Institute, London, England, UK Heidi Welch - Babraham Institute, Cambridge, UK Michael White - UT Southwestern Medical Center, Dallas, TX, US David Williams - Boston Children's Hospital, Boston, MA, US Jeffrey A. Frost - University of Texas, Houston, TX
National Library of Medicine - PubMed Central (PMC)
U.S. National Library of Medicine - MEDLINE
Open access
Small GTPases is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})